BioCentury | Jul 15, 2013
Clinical News

Evicel regulatory update

...EMA's CHMP issued a positive opinion recommending expanding the label of Evicel fibrin sealant from Johnson...
...fibrin sealant from Johnson & Johnson to include suture line sealing in dura mater closure. Evicel...
...2008 & Jan. 5, 2009). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product: Evicel ( Fibrin/Sealant ll...
BioCentury | Dec 3, 2012
Clinical News

Evicel regulatory update

...issued recommendations to reduce the risk of gas embolism during spray application of fibrin sealants Evicel...
...administer the medicines. J&J is withdrawing Quixil from the European market and replacing it with Evicel...
...2008 & Jan. 5, 2009). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product: Evicel ( Fibrin/Sealant ll...
BioCentury | Jul 19, 2010
Clinical News

Artiss regulatory update

...products using air- or gas-pressurized sprayers. Products affected include Artiss and Tisseel from Baxter, and Evicel...
...Inc. (NYSE:BAX), Deerfield, Ill. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product: Artiss; Evicel ( Fibrin/Sealant ll...
BioCentury | Jan 12, 2009
Finance

New products to watch

...Nosocomial pneumonia (NP), complicated intra-abdominal infections and complicated urinary tract infections (cUTI) EU J&J (NYSE:JNJ) Evicel...
BioCentury | Jan 5, 2009
Finance

4Q approvals

...metastatic squamous cell carcinoma of the head and neck (SCCHN) Omrix (NASDAQ:OMRI)/J&J (NYSE:JNJ) EC approves Evicel...
BioCentury | Dec 8, 2008
Finance

Ebb & Flow

...Pad and has exclusive U.S. and EU distribution rights to two biologic-based hemostats from Omrix: Evicel...
BioCentury | Dec 8, 2008
Company News

Omrix, J&J deal

...fibrin sealant for hemostasis and other surgical applications. J&J's Ethicon Inc. subsidiary already markets Omrix's Evicel...
BioCentury | Nov 25, 2008
Top Story

J&J to acquire Omrix

...already has exclusive U.S. and EU distribution rights to two biologic-based hemostats from Omrix -- Evicel...
BioCentury | Oct 20, 2008
Finance

Ebb & Flow

...$11.32. Omrix (NASDAQ:OMRI) was up $2.86 (25%) to $14.48 last week after the EC approved Evicel...
BioCentury | Oct 15, 2008
Company News

Evicel approved in Europe

...The EC approved Evicel from Omrix (NASDAQ:OMRI) for use as a supportive treatment in surgery where...
Items per page:
1 - 10 of 25